PhotoPharmics
PrivateLast Round
Series B
Extension
Apr 18, 2025
Total Funding Raised
$22.64M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PhotoPharmics is a clinical-stage medical device company developing next-generation photo-neuromodulation therapies for neurodegenerative disorders, with an initial focus on Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PhotoPharmics Comparables
Compare PhotoPharmics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gondola Medical Technologies | 79% | |
| Cala Health | 79% | |
| Vielight Inc. | 78% | |
PhotoPharmics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Apr 18, 2025 | ||||
| Series B | Nov 15, 2023 | ||||
| Grant | Sep 24, 2021 | ||||
| Series B | Apr 29, 2020 |
PhotoPharmics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Frazier Group | Series B |
| Vectra Management Group | Series B |
| NIH RADx | Grant |
| Kickstart | Series B Extension, Series B |
| Angel Star Ventures | Series B |
| Frazier VC | Convertible Debt, Seed |
| National Institute on Drug Abuse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors increased 36% MoM.
- Apr 18, 2025
$6M round led by Kickstart.
PhotoPharmics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PhotoPharmics's valuation, stock price, and market status.